TuHURA Biosciences, Kineta stockholders approve merger and related proposals

TuHURA Biosciences (HURA) announced with Kineta (KANT) that TuHURA stockholders approved all of the proposals set forth at the company’s special meeting of stockholders held today, June 23. The proposals included an increase of the company’s authorized shares to 200M shares and a proposal to reincorporate the company in Delaware. Additionally, Kineta stockholders approved the proposed merger with TuHURA at Kineta’s special meeting. The parties anticipate that the merger will close as soon as possible following the satisfaction or waiver of any remaining closing conditions.